Class information for:
Level 1: DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER//ETAFTORON//HOSP XIAMEN AFFILIATED 1

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
27413 188 27.7 46%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
708 12194 CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER Author keyword 1 50% 1% 1
2 ETAFTORON Author keyword 1 50% 1% 1
3 HOSP XIAMEN AFFILIATED 1 Address 1 50% 1% 1
4 MED VIRGINIA STN Address 1 50% 1% 1
5 NILUDIPINE Author keyword 1 50% 1% 1
6 OBESE HYPERTENSIVE PATIENTS Author keyword 1 50% 1% 1
7 NON INSULIN DEPENDENT DIABETES NIDDM Author keyword 0 33% 1% 1
8 EFFECTIVE DOSAGE Author keyword 0 25% 1% 1
9 NONDIABETIC PATIENTS Author keyword 0 25% 1% 1
10 PRIMARY CULTURES OF RAT HEPATOCYTES Author keyword 0 25% 1% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER 1 50% 1% 1 Search DIHYDROPYRIDINE+TYPE+CALCIUM+CHANNEL+BLOCKER Search DIHYDROPYRIDINE+TYPE+CALCIUM+CHANNEL+BLOCKER
2 ETAFTORON 1 50% 1% 1 Search ETAFTORON Search ETAFTORON
3 NILUDIPINE 1 50% 1% 1 Search NILUDIPINE Search NILUDIPINE
4 OBESE HYPERTENSIVE PATIENTS 1 50% 1% 1 Search OBESE+HYPERTENSIVE+PATIENTS Search OBESE+HYPERTENSIVE+PATIENTS
5 NON INSULIN DEPENDENT DIABETES NIDDM 0 33% 1% 1 Search NON+INSULIN+DEPENDENT+DIABETES+NIDDM Search NON+INSULIN+DEPENDENT+DIABETES+NIDDM
6 EFFECTIVE DOSAGE 0 25% 1% 1 Search EFFECTIVE+DOSAGE Search EFFECTIVE+DOSAGE
7 NONDIABETIC PATIENTS 0 25% 1% 1 Search NONDIABETIC+PATIENTS Search NONDIABETIC+PATIENTS
8 PRIMARY CULTURES OF RAT HEPATOCYTES 0 25% 1% 1 Search PRIMARY+CULTURES+OF+RAT+HEPATOCYTES Search PRIMARY+CULTURES+OF+RAT+HEPATOCYTES
9 RAT HEPATOCYTE PRIMARY CULTURE 0 25% 1% 1 Search RAT+HEPATOCYTE+PRIMARY+CULTURE Search RAT+HEPATOCYTE+PRIMARY+CULTURE
10 GLYCOREGULATION 0 20% 1% 1 Search GLYCOREGULATION Search GLYCOREGULATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ISLET FUNCTION 1 10% 6% 11
2 HYPERTENSIVE DIABETICS 0 33% 1% 1
3 NIFEDIPINE TREATMENT 0 17% 1% 1
4 RESISTANT OBESE 0 11% 1% 1
5 1ST STEP TREATMENT 0 100% 1% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
HORMONAL AND METABOLIC EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS IN MAN 1988 49 73 32%
CALCIUM ENTRY BLOCKERS AND THEIR EFFECTS ON GLUCOSE-METABOLISM 1990 2 41 54%
PHARMACOLOGY AND TOXICOLOGICAL PROFILE OF LAS-30538 - A NEW VASCULAR SELECTIVE CA2+ CHANNEL BLOCKER 1995 0 9 44%
EFFECTS OF DRUGS ON GLUCOSE-TOLERANCE IN NON-INSULIN-DEPENDENT DIABETICS .2. 1990 15 119 12%
THE CHOICE OF ANTIHYPERTENSIVE THERAPY IN THE DIABETIC PATIENT 1985 23 24 25%
EFFECTS OF CALCIUM-ANTAGONISTS ON CARBOHYDRATE AND LIPID-METABOLISM 1992 0 40 38%
CALCIUM-ANTAGONISTS AND GLYCEMIC CONTROL 1986 7 26 35%
USE OF ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH GLUCOSE-INTOLERANCE 1985 8 29 38%
MODERN ASPECTS OF THE MECHANISM OF CALCIUM-ANTAGONIST ACTION IN DIABETIC-PATIENTS 1992 0 32 9%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HOSP XIAMEN AFFILIATED 1 1 50% 0.5% 1
2 MED VIRGINIA STN 1 50% 0.5% 1
3 MED VIRGINIA HLTH SCIBOX 498 0 100% 0.5% 1
4 SCUOLA MED IST MED ENDOCRINOL 0 100% 0.5% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000216973 HYPERINSULINEMIA//SUGAR INDUCED HYPERTENSION//ATHEROSCLEROSIS METAB CLIN NUTR
2 0.0000213255 ELGODIPINE//NISOLDIPINE//GALLOPAMIL
3 0.0000212098 DOXAZOSIN//AJ 2615//MONATEPIL MALEATE
4 0.0000198571 FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE
5 0.0000161583 ISRADIPINE//CAS 75695 93 1//DENSITY DEPENDENT GROWTH INHIBITION
6 0.0000130950 NORVERAPAMIL//CLIN PHARMACOL GERIATR MED//S VERAPAMIL
7 0.0000100115 A23187 CALCIUM IONOPHORE//BRANCHED ALKANOL//DIABETIC HYPERTENSIVE PATIENTS
8 0.0000097113 UNITE PHARMACOEPIDEMIOL EA 3696//BLOOD POTASSIUM//HYPERGLUCAGONAEMIA
9 0.0000087852 LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE
10 0.0000084232 ANTIHYPERTENSIVE PHARMACOTHERAPY//BETA1 BLOCKADE//CARDIOVASC P REHABIL UNIT